Management of Compromised Splanchnic Circulation

Introduction to Splanchnic Circulation Management

The American Association for the Study of Liver Diseases recommends managing compromised splanchnic circulation with a combination of hemodynamic optimization, pharmacological therapy targeting portal pressure reduction, and consideration of mechanical interventions based on the underlying cause and severity of ischemia 1, 2

The European Society of Intensive Care Medicine suggests maintaining mean arterial pressure (MAP) >65 mmHg to ensure adequate perfusion pressure for splanchnic organs while avoiding fluid overload 3
The Society of Critical Care Medicine recommends targeting hemoglobin levels >7 g/dL (4.5 mmol/L) during resuscitation phase to optimize oxygen delivery to splanchnic tissues 3
The American College of Chest Physicians advises monitoring perfusion pressure (MAP minus central venous pressure) as this directly affects organ blood flow according to the relationship: Q = dP/R (flow = pressure gradient/resistance) 4
The World Society of Abdominal Compartment Syndrome suggests assessing intra-abdominal pressure (IAP) and considering therapeutic reduction using diuretics or peritoneal drainage for IAP >12 mmHg, with surgical decompression for IAP >30 mmHg to restore splanchnic perfusion 4

The American Association for the Study of Liver Diseases recommends using vasoactive drugs that cause splanchnic vasoconstriction, such as non-selective beta-blockers (NSBBs) like propranolol or nadolol, to reduce portal pressure through β2-blockade (causing splanchnic vasoconstriction) and β1-blockade (decreasing cardiac output) 1, 2, 5
The European Society of Gastrointestinal Endoscopy suggests temporarily suspending beta-blockers during acute bleeding episodes 6
The American College of Gastroenterology recommends using terlipressin (2 mg IV every 4 hours, titrated down to 1 mg IV every 4 hours once bleeding is controlled) for acute management of bleeding related to portal hypertension, as it is effective with fewer side effects than vasopressin 7, 8
The Infectious Diseases Society of America advises administering prophylactic antibiotics (norfloxacin 400 mg BID for 7 days or IV ceftriaxone 1 g/day in advanced cirrhosis) in cases of gastrointestinal bleeding to prevent bacterial infections 8

The Society of Interventional Radiology recommends considering transjugular intrahepatic portosystemic shunt (TIPS) for connecting hypertensive portal vein with normotensive hepatic vein in cases of refractory bleeding or severe portal hypertension 1, 2
The American Gastroenterological Association suggests using balloon-occluded retrograde transvenous obliteration (BRTO) for gastric varices 1, 2
The European Society of Gastrointestinal Endoscopy recommends using endoscopic variceal ligation (EVL) or cyanoacrylate injection for varices 1, 2

The American Association for the Study of Liver Diseases recommends using hepatic venous pressure gradient (HVPG) measurement to assess portal pressure when possible - normal is 3-5 mmHg, with clinically significant portal hypertension defined as HVPG ≥10 mmHg 9
The Society of Critical Care Medicine suggests monitoring urine output as an indicator of adequate renal perfusion pressure 4

The European Society of Intensive Care Medicine advises avoiding excessive fluid resuscitation which can exacerbate portal pressure, impair clot formation, and increase bleeding risk 3
The American College of Gastroenterology recommends avoiding beta-blockers during acute bleeding episodes as they decrease blood pressure and blunt physiologic heart rate response 7
The American Association for the Study of Liver Diseases suggests avoiding vasopressin without nitroglycerin due to risk of significant systemic vasoconstriction and ischemic complications 7